InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 1.63 USD 12.41% Market Closed
Updated: May 19, 2024

InflaRx NV
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InflaRx NV
Cost of Revenue Peer Comparison

Comparables:
BNTX
MOR
CVAC
IMTX
BIO

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Cost of Revenue
-€752.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cost of Revenue
-€599.8m
CAGR 3-Years
-117%
CAGR 5-Years
-112%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cost of Revenue
-€32.8m
CAGR 3-Years
-44%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Cost of Revenue
-€116.3m
CAGR 3-Years
-102%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cost of Revenue
-€528.9m
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-6%

See Also

What is InflaRx NV's Cost of Revenue?
Cost of Revenue
-752.8k EUR

Based on the financial report for Mar 31, 2024, InflaRx NV's Cost of Revenue amounts to -752.8k EUR.